# Vistagen Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:f0af789b-68d0-4008-be64-850a89cf9fea | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/vistagen-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:47:24.361527+00:00 | | Last reviewed | 2026-10-16T04:47:24.361527+00:00 | ## Identity - Legal name: Vistagen Therapeutics, Inc. - Display name: Vistagen Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T09:42:50.399642+00:00 | | Completeness | 0.409 | | Record Quality | 0.843 | | Directors | 6 | | Committees | 2 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ann M. Cunningham, MBA: Director. Status: current. Independent: false. Since: 2019-01-01. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:5 - Joanne Curley, Ph.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:6 - Jon S. Saxe, J.D., LL.M.: Director. Status: current. Independent: true. Since: 2000-01-01. Committees: Audit (chair); Compensation (member). claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:7 - Margaret M. FitzPatrick, M.A.: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:8 - Michael V. Greco, J.D.: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:9 - Shawn K. Singh, J.D.: Director. Status: current. Independent: false. Since: 2009-01-01. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:10 ## Committees - Audit (audit). Chair: Jon S. Saxe, J.D., LL.M.. Members: Jon S. Saxe, J.D., LL.M. (chair, current); Michael V. Greco, J.D. (member, current). committee_id=alpha:committee:vistagen-therapeutics-inc:audit - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Jon S. Saxe, J.D., LL.M. (member, current); Margaret M. FitzPatrick, M.A. (member, current). committee_id=alpha:committee:vistagen-therapeutics-inc:compensation ## Executive leadership - Cynthia L. Anderson, CPA: Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:11 - Elissa Cote: Chief Corporate Development Officer. Status: current. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:12 - Joshua S. Prince, MBA: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:13 - Reid G. Adler, J.D.: Chief Legal Officer [GC]. Status: current. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:14 - Shawn K. Singh, J.D.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:15 ## Governance events - CFO_CHANGED: Cynthia L. Anderson, CPA executive of Vistagen Therapeutics, Inc., effective 2025-07-28. Effective: 2025-07-28. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:17pjoswbmcje8 - EXECUTIVE_APPOINTED: Elissa Cote executive of Vistagen Therapeutics, Inc., effective 2025-07-28. Effective: 2025-07-28. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:1xrwwvcxayngm - EXECUTIVE_APPOINTED: Joshua S. Prince, MBA executive of Vistagen Therapeutics, Inc., effective 2025-07-28. Effective: 2025-07-28. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:12rgueh1xtvz6b - GC_CHANGED: Reid G. Adler, J.D. executive of Vistagen Therapeutics, Inc., effective 2025-07-28. Effective: 2025-07-28. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:1h5qmtfjpvt0t - CEO_CHANGED: Shawn K. Singh, J.D. executive of Vistagen Therapeutics, Inc., effective 2025-07-28. Effective: 2025-07-28. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:1w52wvk19o9ube - DIRECTOR_APPOINTED: Joanne Curley, Ph.D. seat on Vistagen Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:qsa82k12sscyw - DIRECTOR_APPOINTED: Margaret M. FitzPatrick, M.A. seat on Vistagen Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:y4kive153xm1i - DIRECTOR_APPOINTED: Michael V. Greco, J.D. seat on Vistagen Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:17u94fx16g9a23 - DIRECTOR_APPOINTED: Ann M. Cunningham, MBA seat on Vistagen Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:482gjc69u6yo - DIRECTOR_APPOINTED: Shawn K. Singh, J.D. seat on Vistagen Therapeutics, Inc., effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:drz8gp7jybvh - DIRECTOR_APPOINTED: Jon S. Saxe, J.D., LL.M. seat on Vistagen Therapeutics, Inc., effective 2000-01-01. Effective: 2000-01-01. Detected: 2026-10-16T04:47:24.361527+00:00. event_id=alpha:event:transition:1ibce6e89us36 ## Scoped resources - `alpha://company/vistagen-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record - `alpha://company/vistagen-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=identity - `alpha://company/vistagen-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/vistagen-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=board - `alpha://company/vistagen-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=committees - `alpha://company/vistagen-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=leadership - `alpha://company/vistagen-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=ownership - `alpha://company/vistagen-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=financials - `alpha://company/vistagen-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/vistagen-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=compensation - `alpha://company/vistagen-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=governance - `alpha://company/vistagen-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/vistagen-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=audit - `alpha://company/vistagen-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=legal - `alpha://company/vistagen-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=risk - `alpha://company/vistagen-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=cyber - `alpha://company/vistagen-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/vistagen-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=agents - `alpha://company/vistagen-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/vistagen-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=events - `alpha://company/vistagen-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=relationships - `alpha://company/vistagen-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=assessments - `alpha://company/vistagen-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:jon-s-saxe-j-d-ll-m","name":"Jon S. Saxe, J.D., LL.M."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mary-l-rotunno-j-d","name":"Michael V. Greco, J.D."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jon-s-saxe-j-d-ll-m","name":"Jon S. Saxe, J.D., LL.M."},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:margaret-m-fitzpatrick-m-a","name":"Margaret M. FitzPatrick, M.A."},"source_id":"governance_people_committees"}` ## Leadership - Ann M. Cunningham, MBA: Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd. - Joanne Curley, Ph.D.: Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd. - Jon S. Saxe, J.D., LL.M.: Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:7. Valid from: 2000-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd. - Margaret M. FitzPatrick, M.A.: Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd. - Michael V. Greco, J.D.: Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd. - Shawn K. Singh, J.D.: Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:10. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd. - Cynthia L. Anderson, CPA: Vice President and Chief Financial Officer. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:11. Valid from: 2025-07-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:72be2e5aa7070b77530e2bdff475a066a2919709e5c1b0759e4dc38207fbc3b3. - Elissa Cote: Chief Corporate Development Officer. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:12. Valid from: 2025-07-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:27a67467e550c7d921d2d9fc4360228d30a0e566447d7242eecb5124e9ebd478. - Joshua S. Prince, MBA: Chief Operating Officer. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:13. Valid from: 2025-07-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f62652fa6fc29a46f245d1d9c256701064d1054eba11d4f1c1c2f6ec2542b5e2. - Reid G. Adler, J.D.: Chief Legal Officer. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:14. Valid from: 2025-07-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eb1d25b407d233d3ecd3cf879a89282e8f8d9da7fb99c5c995d99f0674ff383d. - Shawn K. Singh, J.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:leadership_role:15. Valid from: 2025-07-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:71157fa01fcd4033cd23226907982a049f48c52030ca35ed888b006e1353f718. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Jon S. Saxe, J.D., LL.M.; Members Jon S. Saxe, J.D., LL.M. (Chair); Michael V. Greco, J.D.. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af. - Compensation: Chair not stated; Members Jon S. Saxe, J.D., LL.M.; Margaret M. FitzPatrick, M.A.. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Vistagen Therapeutics, Inc.. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1884ed352e08aec56a918b38f5c02bc63305eea170fb357c9885cfbf58542e77. ## Entity Status - Public listing published. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1884ed352e08aec56a918b38f5c02bc63305eea170fb357c9885cfbf58542e77. ## Published Fact - US. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1884ed352e08aec56a918b38f5c02bc63305eea170fb357c9885cfbf58542e77. ## Committee Appointment - Jon S. Saxe, J.D., LL.M.: chair, Audit. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af. - Michael V. Greco, J.D.: member, Audit. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af. - Jon S. Saxe, J.D., LL.M.: member, Compensation. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af. - Margaret M. FitzPatrick, M.A.: member, Compensation. Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af. ## Security Listing - VTGN (NASDAQ). Claim: alpha:claim:company:f0af789b-68d0-4008-be64-850a89cf9fea:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1884ed352e08aec56a918b38f5c02bc63305eea170fb357c9885cfbf58542e77. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:1884ed352e08aec56a918b38f5c02bc63305eea170fb357c9885cfbf58542e77: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vistagen-therapeutics-inc). - alpha:projection-evidence:document:ecfc3895a5cf7884fbbdc20bedc8baf433f7ba6f0dba7fab683b8e7d070bc3dd: [Vistagen Therapeutics, Inc. DEF 14A 2025-07-28](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). - alpha:projection-evidence:document:72be2e5aa7070b77530e2bdff475a066a2919709e5c1b0759e4dc38207fbc3b3: [VTGN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). - alpha:projection-evidence:document:27a67467e550c7d921d2d9fc4360228d30a0e566447d7242eecb5124e9ebd478: [VTGN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). - alpha:projection-evidence:document:f62652fa6fc29a46f245d1d9c256701064d1054eba11d4f1c1c2f6ec2542b5e2: [VTGN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). - alpha:projection-evidence:document:eb1d25b407d233d3ecd3cf879a89282e8f8d9da7fb99c5c995d99f0674ff383d: [VTGN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). - alpha:projection-evidence:document:71157fa01fcd4033cd23226907982a049f48c52030ca35ed888b006e1353f718: [VTGN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). - alpha:projection-evidence:2d55ca37f872ae1a3652764877742eab97af8206e2bd9588130699382fbe79af: [Audit](https://www.sec.gov/Archives/edgar/data/1411685/000141168525000052/vtgn-20250728.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/vistagen-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/vistagen-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/vistagen-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/vistagen-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T09:42:50.145224+00:00; recorded 2026-10-16T09:42:50.145224+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.